Fangyang Jiao

434 total citations
21 papers, 256 citations indexed

About

Fangyang Jiao is a scholar working on Neurology, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Fangyang Jiao has authored 21 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 10 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Physiology. Recurrent topics in Fangyang Jiao's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (7 papers) and Alzheimer's disease research and treatments (6 papers). Fangyang Jiao is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (7 papers) and Alzheimer's disease research and treatments (6 papers). Fangyang Jiao collaborates with scholars based in China, Switzerland and Germany. Fangyang Jiao's co-authors include Chuantao Zuo, Yihui Guan, Jiaying Lu, Weiqi Bao, Ping Wu, Shenxun Shi, Hui Su, Fengtao Liu, Huiwei Zhang and Jingjie Ge and has published in prestigious journals such as Scientific Reports, Movement Disorders and Frontiers in Neuroscience.

In The Last Decade

Fangyang Jiao

21 papers receiving 253 citations

Peers

Fangyang Jiao

NEURO

RNMI

PHYSI

CMN

Michela Ferrara Italy

Peiyuan F. Hsieh Taiwan

Júlio César Claudino dos Santos Brazil

Runcheng He China

Silvia Ríos‐Romenets Colombia

Qingxia Lin China

Babak Tousi United States

Wasim Khan Australia

Harald G. Scholand-Engler Germany

Michela Ferrara Italy

Fangyang Jiao

257 ×2.6

NEURO

41 ×0.6

RNMI

87 ×1.4

PHYSI

123 ×2.1

60 ×1.8

CMN

Citations per year, relative to Fangyang Jiao Fangyang Jiao (= 1×) peers Michela Ferrara

Countries citing papers authored by Fangyang Jiao

Since Specialization

Citations

This map shows the geographic impact of Fangyang Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyang Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyang Jiao more than expected).

Fields of papers citing papers by Fangyang Jiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangyang Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyang Jiao. The network helps show where Fangyang Jiao may publish in the future.

Co-authorship network of co-authors of Fangyang Jiao

This figure shows the co-authorship network connecting the top 25 collaborators of Fangyang Jiao. A scholar is included among the top collaborators of Fangyang Jiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangyang Jiao. Fangyang Jiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Shiyu, Fangyang Jiao, Tianyu Hu, et al.. (2025). Plasma GFAP and NfL associate with cerebral glucose metabolism in putative brain-first and body-first Parkinson’s disease subtypes. npj Parkinson s Disease. 11(1). 54–54. 1 indexed citations

Lu, J. G., Fangyang Jiao, Ping Wu, et al.. (2025). Annual percentage change of MR Parkinsonism index in progressive supranuclear palsy: a feasibility study. European Radiology. 35(9). 5525–5536. 3 indexed citations

Jiao, Fangyang, Qingmin Wang, Jiaying Lu, et al.. (2025). Relationships Between Glymphatic System Activity and Tau Burden, Dopaminergic Impairment, Abnormal Glucose Metabolism in Progressive Supranuclear Palsy. CNS Neuroscience & Therapeutics. 31(2). e70284–e70284. 2 indexed citations

Zhang, Qi, Jiaying Lu, Luyao Wang, et al.. (2025). Evaluating 18F-Florzolotau tau PET for Alzheimer’s disease diagnosis with 18F-Flortaucipir as reference. Journal of Neurology. 272(9). 597–597. 1 indexed citations

Li, Xinyi, Yujie Yang, Fangyang Jiao, et al.. (2024). Rapid Cognitive Deterioration in Progressive Supranuclear Palsy: A 1‐Year Follow‐Up Study. Movement Disorders Clinical Practice. 12(4). 475–483. 1 indexed citations

Wang, Jing, Jiehui Jiang, Fengtao Liu, et al.. (2024). Diagnostic performance of artificial intelligence-assisted PET imaging for Parkinson’s disease: a systematic review and meta-analysis. npj Digital Medicine. 7(1). 17–17. 17 indexed citations

Jiao, Fangyang, Thomas Pyka, Jingjie Ge, et al.. (2024). Dopaminergic PET to SPECT domain adaptation: a cycle GAN translation approach. European Journal of Nuclear Medicine and Molecular Imaging. 52(3). 851–863. 4 indexed citations

Liu, Fengtao, Jiaying Lu, Xinyi Li, et al.. (2023). 18F-Florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy. European Journal of Nuclear Medicine and Molecular Imaging. 50(5). 1395–1405. 27 indexed citations

Lu, Jiaying, Min Wang, Xun Sun, et al.. (2023). Feasibility of 18F-florzolotau quantification in patients with Alzheimer’s disease based on an MRI-free tau PET template. European Radiology. 33(7). 4567–4579. 4 indexed citations

10.

Jiao, Fangyang, Min Wang, Jiaying Lu, et al.. (2023). Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment. Brain Sciences. 13(2). 367–367. 10 indexed citations

11.

Tang, Yilin, Tianyu Hu, Fangyang Jiao, et al.. (2022). In Vivo ¹⁸F‐Florzolotau Tau Positron Emission Tomography Imaging in Parkinson's Disease Dementia. Movement Disorders. 38(1). 147–152. 14 indexed citations

12.

Liu, Fengtao, Xinyi Li, Jiaying Lu, et al.. (2022). ¹⁸F‐Florzolotau Tau Positron Emission Tomography Imaging in Patients with Multiple System Atrophy–Parkinsonian Subtype. Movement Disorders. 37(9). 1915–1923. 13 indexed citations

13.

Lu, Jiaying, Xinyi Li, Fangyang Jiao, et al.. (2022). Striatal dopaminergic lesions contributed to the disease severity in progressive supranuclear palsy. Frontiers in Aging Neuroscience. 14. 998255–998255. 6 indexed citations

14.

Li, Zhuoyuan, Jiaying Lu, Fangyang Jiao, et al.. (2022). In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer’s Disease: A 18F-Florzolotau Study. Brain Sciences. 12(10). 1355–1355. 3 indexed citations

15.

Xu, Jiahang, Fangyang Jiao, Yechong Huang, et al.. (2019). A Fully Automatic Framework for Parkinson’s Disease Diagnosis by Multi-Modality Images. Frontiers in Neuroscience. 13. 874–874. 5 indexed citations

16.

Jiao, Fangyang, Kuangyu Shi, Xize Jia, et al.. (2019). Frequency-Dependent Relationship Between Resting-State fMRI and Glucose Metabolism in the Elderly. Frontiers in Neurology. 10. 566–566. 20 indexed citations

17.

Su, Hui, Chao Zuo, Huiwei Zhang, et al.. (2018). Regional cerebral metabolism alterations affect resting-state functional connectivity in major depressive disorder. Quantitative Imaging in Medicine and Surgery. 8(9). 910–924. 32 indexed citations

18.

Sang, Shaoming, Xiaoli Pan, Zhichun Chen, et al.. (2018). Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not. Alzheimer s Research & Therapy. 10(1). 26–26. 48 indexed citations

19.

Li, Yingying, Bei Zhang, Kewei Yu, et al.. (2017). Effects of constraint-induced movement therapy on brain glucose metabolism in a rat model of cerebral ischemia: a micro PET/CT study. International Journal of Neuroscience. 128(8). 736–745. 17 indexed citations

20.

Yi, Bin, Chuantao Zuo, Fangyang Jiao, et al.. (2016). Effects of long-term salicylate administration on synaptic ultrastructure and metabolic activity in the rat CNS. Scientific Reports. 6(1). 24428–24428. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact